101 related articles for article (PubMed ID: 19895231)
1. Key signaling molecules in pituitary tumors.
Tanase CP; Neagu M; Albulescu R
Expert Rev Mol Diagn; 2009 Nov; 9(8):859-77. PubMed ID: 19895231
[TBL] [Abstract][Full Text] [Related]
2. Hormonal signaling and pituitary adenomas.
Spada A; Lania A; Mantovani G
Neuroendocrinology; 2007; 85(2):101-9. PubMed ID: 17337884
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction pathways in human epidermis.
Iversen L; Johansen C; Kragballe K
Eur J Dermatol; 2005; 15(1):4-12. PubMed ID: 15701586
[TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
5. Pituitary tumour pathogenesis.
Heaney AP
Br Med Bull; 2005; 75-76():81-97. PubMed ID: 16684928
[TBL] [Abstract][Full Text] [Related]
6. The importance of growth factors and steroid hormones in ovarian cancer.
Langdon SP; Faratian D; Harrison DJ
Onkologie; 2009 Nov; 32(11):623-4. PubMed ID: 19887864
[No Abstract] [Full Text] [Related]
7. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
8. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
9. Intracellular signal transduction pathway proteins as targets for cancer therapy.
Adjei AA; Hidalgo M
J Clin Oncol; 2005 Aug; 23(23):5386-403. PubMed ID: 15983388
[TBL] [Abstract][Full Text] [Related]
10. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
Favoni RE; de Cupis A
Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between IGF-I and TGF-beta signaling pathways.
Danielpour D; Song K
Cytokine Growth Factor Rev; 2006; 17(1-2):59-74. PubMed ID: 16297654
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
13. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into how purines regulate pituitary cell function.
Rees DA; Scanlon MF; Ham J
Clin Sci (Lond); 2003 May; 104(5):467-81. PubMed ID: 12578557
[TBL] [Abstract][Full Text] [Related]
15. Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
Cakir M; Grossman AB
Expert Opin Ther Targets; 2009 Sep; 13(9):1121-34. PubMed ID: 19637976
[TBL] [Abstract][Full Text] [Related]
16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
17. [Drug resistance mediated by survival- and growth-promoting signaling pathways].
Fujita N
Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028
[TBL] [Abstract][Full Text] [Related]
18. Proteoglycans in the control of tumor growth and metastasis formation.
Cattaruzza S; Nicolosi PA; Perris R
Connect Tissue Res; 2008; 49(3):225-9. PubMed ID: 18661348
[TBL] [Abstract][Full Text] [Related]
19. Chemokine stromal cell-derived factor 1alpha induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals.
Florio T; Casagrande S; Diana F; Bajetto A; Porcile C; Zona G; Thellung S; Arena S; Pattarozzi A; Corsaro A; Spaziante R; Robello M; Schettini G
Mol Pharmacol; 2006 Feb; 69(2):539-46. PubMed ID: 16258074
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between nuclear receptors and nuclear factor kappaB.
De Bosscher K; Vanden Berghe W; Haegeman G
Oncogene; 2006 Oct; 25(51):6868-86. PubMed ID: 17072333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
